These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4065022)

  • 21. Lactoferrin serum levels in burned patients.
    Chiarelli A; Casadei A; Andrian C; Ongaro G; Mazzoleni F
    Boll Ist Sieroter Milan; 1985; 64(1):86-8. PubMed ID: 4005063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lactoferrin reflects neutrophil activation in psoriasis.
    Kähler S; Christophers E; Schröder JM
    Br J Dermatol; 1988 Sep; 119(3):289-93. PubMed ID: 3179202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lactoferrin and leukocytes in the blood of oncologic patients].
    Sukharev AE; Nikolaev AA; Vasil'ev MIu
    Lab Delo; 1990; (8):33-5. PubMed ID: 1705597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lactoferrin in human lung tumors].
    Sergeeva NS; Vasil'ev MIu
    Eksp Onkol; 1985; 7(2):64-7. PubMed ID: 3924554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of a 21-kDa protein in the circulation of tumor-bearing patients.
    Shalitin C; Epelbaum R; Moskovitz B; Segal R; Valansi C; Werner M; Livne PM
    Cancer Detect Prev; 1994; 18(5):357-65. PubMed ID: 7812982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of lactoferrin in children suffering from cystic fibrosis.
    Benini L; Agostini M; Vaona B; Brocco G; Vantini I; Cavallini G; Mastella G; Scuro LA
    Digestion; 1985; 31(4):200-4. PubMed ID: 4007292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum human alpha-lactalbumin as a marker for breast cancer.
    Thean ET; Toh BH
    Br J Cancer; 1990 May; 61(5):773-5. PubMed ID: 2337516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of colony-stimulating factor (CSF) production by postburn serum: negative feedback inhibition mediated by lactoferrin.
    Peterson VM; Ambruso DR; Emmett M; Bartle EJ
    J Trauma; 1988 Nov; 28(11):1533-40. PubMed ID: 3263509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum her-2/neu level and related factors in patients with breast cancer].
    Yuan P; Xu BH; Zhang C; Qi J
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):573-4. PubMed ID: 14690565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on human alpha-lactalbumin: radioimmunoassay measurements in normal human breast and breast cancer.
    Kleinberg DL; Todd J; Groves ML
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1238-50. PubMed ID: 22554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A solid-phase radioimmunoassay for the measurement of lactoferrin in human plasma: variations with age, sex, and disease.
    Bennett RM; Mohla C
    J Lab Clin Med; 1976 Jul; 88(1):156-66. PubMed ID: 1064675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measurement of fecal lactoferrin for diagnosis on pediatric gastrointestinal disease].
    Tabata K; Matsuse R; Uchida K; Amemoto K
    Rinsho Byori; 1997 Dec; 45(12):1201-3. PubMed ID: 9437905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactoferrin as an indicator of septicemia and endotoxemia in pigs.
    Gutteberg TJ; Røkke O; Jørgensen T; Andersen O
    Scand J Infect Dis; 1988; 20(6):659-66. PubMed ID: 3065932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients.
    Larsen MB; Stephens RW; Brünner N; Nielsen HJ; Engelholm LH; Christensen IJ; Stetler-Stevenson WG; Høyer-Hansen G
    Scand J Immunol; 2005 May; 61(5):449-60. PubMed ID: 15882437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S; Szmitkowski M; Wojtukiewicz M
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and characterization of murine monoclonal antibody to human alpha-lactalbumin.
    Thean ET; Toh BH
    Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():41-8. PubMed ID: 2722208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients.
    Hebbar M; Révillion F; Louchez MM; Fournier C; Bonneterre J; Peyrat JP
    Clin Cancer Res; 1999 Jun; 5(6):1427-33. PubMed ID: 10389928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
    Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
    Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.